Skip to main content
. 2021 Jun 8;12:673025. doi: 10.3389/fgene.2021.673025

TABLE 5.

Size of the deletions and haploinsufficient genes located within the atypical NF1 deletions.

Patient Deletion size (Mb) Haploinsufficient genes (by gnomAD pLI) References
BUD 4.7 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Kehrer-Sawatzki et al., 2003
3724A 2.0-3.1 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Cnossen et al., 1997
6 3 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Venturin et al., 2004a, b
UWA106-3 3.2-3.7 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Dorschner et al., 2000; Kayes et al., 1992; Kayes et al., 1994
442 2 ATAD5, NF1, OMG, RAB11FIP4, SUZ12 Kehrer-Sawatzki et al., 2005
BL ∼3 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Riva et al., 2000
ID806 ∼7 ATAD5, NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Upadhyaya et al., 1996
UWA155-1 2.1-2.7 NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Upadhyaya et al., 1996
118 N/A ATAD5, NF1 Venturin et al., 2004b
282775 > 1.33 NF1, OMG, RAB11FIP4, SUZ12 Mantripragada et al., 2006
552 2.7 NF1, OMG, RAB11FIP4, SUZ12, PSMD11, CDK5R1, ASIC2 Kehrer-Sawatzki et al., 2008
40 1.27-1.46* NF1, OMG, RAB11FIP4, SUZ12, Zhang et al., 2015
56 0.60-1.14* ATAD5, NF1, OMG
73 0.93-1.28* NF1, OMG, RAB11FIP4, SUZ12
76 1.26-1.63* ATAD5, NF1, OMG, RAB11FIP4, SUZ12
556/NF 1.122 ATAD5, NF1, OMG, RAB11FIP4, SUZ12 This study
125/NF 1.635* ATAD5, NF1, OMG, RAB11FIP4, SUZ12
134/NF 0.618* ATAD5, NF1, OMG
260/NF 0.618* ATAD5, NF1, OMG

*Results originated from MLPA probes location. The probability of loss of function (pLI) metric were provided by the gnomAD browser (https://gnomad.broadinstitute.org/). According to official description, a transcript’s intolerance to variation is measured by predicting the number of variants expected to be seen in the gnomAD dataset and comparing those expectations to the observed amount of variation. The range scales from 0 to 1, where the closer the pLI value is to 1, the more intolerant the gene appears to be to loss of function (LoF) variants. We determined as haploinsufficient a gene if the pLI value was above 0.9, which indicates extreme intolerance to LoF variants (Karczewski et al., 2020).